SCHEMBL5456861

SCHEMBL5456861

c1ccc(-c2ccccc2-c2cc(-c3ccccc3)c3ccc4c(-c5ccccc5)ccnc4c3n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 5/20 0.43
TOP2A P11388 1/20 0.41
IKBKB O14920 1/20 0.41
CHUK O15111 1/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41
IGF1R P08069 1/20 0.41
FGFR1 P11362 1/20 0.41
PRKACA P17612 1/20 0.41
FLT1 P17948 1/20 0.41
LTK P29376 1/20 0.41
GRK5 P34947 1/20 0.41
KDR P35968 1/20 0.41
MAP2K2 P36507 1/20 0.41
MAPK8 P45983 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14581506 0.92 TOP1 (0.42) TOP1TOP2AIKBKBCHUKDAPK3
SCHEMBL1226790 0.90 TOP1 (0.53) TOP1TOP2AIKBKBCHUKDAPK3
SCHEMBL10103585 0.88 SMN1; SMN2 (0.48) TOP1TOP2AIKBKBALDH1A1MAPT
SCHEMBL5463115 0.88 TOP1 (0.39) TOP1TOP2AIKBKBCHUKDAPK3
SCHEMBL440405 0.88 MEN1 (0.40) TOP1TNFALDH1A1MAPTGPR55
SCHEMBL1228190 0.88 PDE4A (0.41) TOP1TOP2AIKBKBCHUKDAPK3
SCHEMBL5452946 0.88 TNF (0.44) TOP1TOP2AIKBKBCHUKDAPK3
SCHEMBL14900758 0.88 TOP1 (0.46) TOP1TOP2AIKBKBCHUKDAPK3
SCHEMBL5456759 0.88 TOP1 (0.50) TOP1TOP2AIKBKBCHUKDAPK3
SCHEMBL5459288 0.86 TOP1 (0.45) TOP1TOP2AIKBKBCHUKDAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070037983-A1 Phenanthroline derivative compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-02-15 US disclosed
US-20070037983-A1 Phenanthroline derivative compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-02-15 US disclosed
US-20070037983-A1 Phenanthroline derivative compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037983-A1 Phenanthroline derivative compound POP1, PABPC1, NAP1L1 TOP1 113/4885TOP2A 550/4885IKBKB 3961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.